Tools
ToolsMurphy, Helen R (2021) 2020 NICE guideline update: Good news for pregnant women with type 1 diabetes and past or current gestational diabetes. Diabetic Medicine, 38 (6). ISSN 0742-3071
Preview |
PDF (Published_Version)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (1MB) | Preview |
Abstract
In December 2020, the National Institute for Health and Care Excellence (NICE) reviewed the evidence and updated their recommendations on intermittently scanned (commonly known as Flash) and Continuous Glucose Monitoring (CGM) during pregnancy for women with type 1 diabetes (1). The NICE guidelines now recommend offering CGM to all pregnant women with type 1 diabetes to help them meet their pregnancy glucose targets and improve neonatal outcomes. Their evidence review, based on the CONCEPTT randomised trial (2) and a Swedish observational study (3) found that, compared to capillary glucose monitoring, CGM resulted in more women achieving their blood glucose targets, fewer caesarean sections and fewer neonatal intensive care admissions.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | internal medicine,endocrinology, diabetes and metabolism,endocrinology,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2724 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 23 Apr 2021 23:50 |
| Last Modified: | 19 Oct 2023 02:57 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/79875 |
| DOI: | 10.1111/dme.14576 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |